(1)
Influence Of Eudragit RSPO And Polycaprolactone On The Release Rate And In Vitro Evaluation In The Formulation Of Sustained Release Orlistat Matrix Microparticles. Journal of Pharmaceutical Negative Results 2022, 1271-1284.